Abstract
Sphincter of Oddi dysfunction has been reported as a cause of acute idiopathic recurrent pancreatitis (IRP). Octreotide, a long-acting somatostatin analogue, is an antisecretory drug used in the treatment and prevention of acute pancreatitis. Its action on sphincter of Oddi motility is controversial and no data are available for IRP patients. The aim of this study was to assess sphincter of Oddi motor response to acute administration of octreotide in patients with past attacks of acute pancreatitis without identification of any evident aetiological factor. Six patients (four male, two female; mean age ± SD, 38.8 ± 9 years) suffering from acute pancreatitis for at least 3 months before the examination were submitted to sphincter of Oddi manometry. After a basal recording lasting at least 2 min, octreotide, 0.05 mg i.v., was administered and the recording repeated. Intraduodenal pressure was taken as the zero reference and the basal sphincter of Oddi pressure and amplitude and frequency of phasic contractions were calculated before and after octreotide administration. No significant pre- vs post-octreotide differences were observed in basal pressure (41.9 ± 24 vs 47.5 ± 33 mm Hg, respectively) or in amplitude of phasic contractions (164.6 ± 33 vs 170.8 ± 18 mm Hg). With a latency of about 1 min, octreotide administration caused a high-frequency phasic activity in all cases (mean frequency, 5.5 ± 2.2 contractions/min before and 9.8 ± 2 after octreotide; P < 0.04). After the procedure acute pancreatitis (prolonged abdominal pain and serum amylase levels more than three-fold the normal values) developed in five patients. In conclusion, our data suggest that acute administration of octreotide may induce tachyoddia and thus a rise in sphincter of Oddi pressure, with possible impairment of biliary-pancreatic outflow.
Similar content being viewed by others
References
Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I: Effect of somatostatin analogue Sandostatin (SMS 201-995) on gastrointestinal, pancreatic, and biliary function and hormone release in normal man. Digestion 36:100–124, 1987
Baxter JN, Imrie CW, McKay CJ: Acute pancreatitis and octreotide. Lancet 49:12–13, 1991
Gullo L, Barbara L: Treatment of pancreatic pseudocysts with octreotide. Lancet 338:540–541, 1991
Ahren B, Tranberg KG, Benmark S: Treatment of pancreatic fistula with the somatostatin analogue OCT 201-995. Br J Surg 75:7–18, 1988
Binmoeller KF, Harris AG, Dumas R, Grimaldi C, Delmont JP: Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 33:1129–1133, 1992
Ahrendt SA, Ahrendt GM, Lillemoe KD, Pitt HA: Effect of octreotide on sphincter of Oddi and gallbladder motility in prairie dogs. Am J Physiol 262:G909-G914, 1992
Binmoeller KF, Dumas R, Harris AG, Delmont JP: Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci 37:773–777, 1992
Cavallini G, Rigo L, Bovo P, Brunori MP, Angelini G, Vaona B, Di Francesco V, Frulloni L, Cocco C, Perobelli L, Andreaus MC, Marcori M, Filippini M, Pederzoli P: Abnormal US response of main pancreatic duct after secretin stimulation in patients with acute pancreatitis of different etiology. J Clin Gastroenterol 18:298–303, 1994
Cavallini G, Rigo L, Brunori MP, Bovo P, Vaona B, Di Francesco V, Frulloni L, Talamini G, Andreaus MC, Marcori M: Effect of octreotide on the dynamics of the main pancreatic duct during US-Secretin test in healthy subjects Gastroenterology 104:A298, 1993 (abstract)
Toouli J, Roberts-Thompson IC, Dent J, Lee J: Sphincter of Oddi motility disorders in patients with idiopathic recurrent pancreatitis. Br J Surg 72:859–863, 1985
Adami GF, Leandri R, Sarles JC: Effect of somatostatin on the rabbit Oddi's sphincter in vivo. Gastroentérol Clin Biol 10:108–111, 1986
Sand J, Tainio H, Nordback I: Peptidergic innervation of human sphincter of Oddi. Dig Dis Sci 39:293–300, 1994
Grace PA, Poston GJ, Williamson RCN: Biliary motility. Gut 31:571–582, 1990
Makhlouf GM: Smooth muscle of the gut.In Textbook of Gastroenterology, T Yamada (ed). Philadelphia, J. B. Lippincot, 1991, pp 61–84
Soudah HC, Hasler WL, Owyang C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 325:1461–1467, 1991
Torsoli A, Corazziari E, Habib FI, De Masi E, Beliotti D, Mazzarella R,et al Frequencies and cycles pattern of the human sphincter of Oddi phasic activity. Gut 27:363–369, 1986
Liu YF, Saccone GTP, Thune A, Baker RA, Harvey JR, Toouli J: Sphincter of Oddi regulates flow by acting as a variable resistor to flow. Am J Physiol 262:G683-G689, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Di Francesco, V., Angelini, G., Bovo, P. et al. Effect of octreotide on sphincter of oddi motility in patients with acute recurrent pancreatitis. Digest Dis Sci 41, 2392–2396 (1996). https://doi.org/10.1007/BF02100133
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02100133